Ketamine News and Research

RSS
Female patients with depression have abnormally high expression levels of glutamate receptor genes

Female patients with depression have abnormally high expression levels of glutamate receptor genes

Healthcare systems miss life-saving treatments learnt on battlefield

Healthcare systems miss life-saving treatments learnt on battlefield

Good news for patients suffering from shingles

Good news for patients suffering from shingles

Neuroprotective compounds can limit damage to the brain during ischemic stroke

Neuroprotective compounds can limit damage to the brain during ischemic stroke

Study finds link between contraband cigarette and illicit drug use among teens in Canada

Study finds link between contraband cigarette and illicit drug use among teens in Canada

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

RSAM, Rettsyndrome.org renew commitment to defeat Rett syndrome

RSAM, Rettsyndrome.org renew commitment to defeat Rett syndrome

New hope for people suffering from depression

New hope for people suffering from depression

Researchers develop rapid-acting antidepressants for treatment-resistant depression

Researchers develop rapid-acting antidepressants for treatment-resistant depression

Naurex's two lead antidepressant programs achieve major milestones

Naurex's two lead antidepressant programs achieve major milestones

IV-administered ketamine effective in patients with chronic PTSD

IV-administered ketamine effective in patients with chronic PTSD

Intranasal ketamine spray confers rapid antidepressant effect in patients with depressive disorder

Intranasal ketamine spray confers rapid antidepressant effect in patients with depressive disorder

Ketamine offers novel treatment for patients with severe depression

Ketamine offers novel treatment for patients with severe depression

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

New treatments for depression on the horizon

New treatments for depression on the horizon

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

Portage acquires approximately 54% equity in Biohaven

Portage acquires approximately 54% equity in Biohaven

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

Chemists able to trace narcotics substances, prescription drugs in Swedish wastewater

Researchers analyze effects of MXE drug usage

Researchers analyze effects of MXE drug usage